Combined package with drug delivery device
Latest Janssen Pharmaceutica NV Patents:
- Radiolabelled MGL PET ligands
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
- Compositions containing ibrutinib
- Processes and intermediates for preparing a Btk inhibitor
In the drawings, the broken lines are for the purpose of illustrating portions of the package that form no part of the claimed design.
Claims
The ornamental design for a combined package with drug delivery device, as shown and described.
D430015 | August 29, 2000 | Himbert |
6228324 | May 8, 2001 | Hasegawa et al. |
D549094 | August 21, 2007 | Oner |
D569721 | May 27, 2008 | Gedanke |
D623935 | September 21, 2010 | Kim et al. |
D697398 | January 14, 2014 | Guevara-ludt |
D743249 | November 17, 2015 | Wintmolders |
D750502 | March 1, 2016 | Kirchmayr |
D754547 | April 26, 2016 | Psimadas |
D758180 | June 7, 2016 | Wintmolders |
9422094 | August 23, 2016 | Niiro |
D765520 | September 6, 2016 | Gunder |
D767985 | October 4, 2016 | Schouten |
D774903 | December 27, 2016 | Joergensen |
D775945 | January 10, 2017 | DiChiara |
D780599 | March 7, 2017 | Tilahun |
D785451 | May 2, 2017 | Biery |
D788936 | June 6, 2017 | Schill et al. |
D790987 | July 4, 2017 | Damon |
D790988 | July 4, 2017 | Vasiliadis |
D804962 | December 12, 2017 | Fox |
D808823 | January 30, 2018 | Greene |
D810556 | February 20, 2018 | Holm |
D814314 | April 3, 2018 | Mecker |
D814918 | April 10, 2018 | Bos |
D818815 | May 29, 2018 | Psimadas |
10053272 | August 21, 2018 | Doherty |
D840800 | February 19, 2019 | Farrell |
D841460 | February 26, 2019 | Toledo |
D842092 | March 5, 2019 | Toledo |
D847253 | April 30, 2019 | Chang |
D847624 | May 7, 2019 | Farrell |
D850289 | June 4, 2019 | McCay |
D853249 | July 9, 2019 | McKendree |
D854408 | July 23, 2019 | Farrell |
D855450 | August 6, 2019 | Klein |
D856793 | August 20, 2019 | Debnath |
D860435 | September 17, 2019 | Wang |
D870550 | December 24, 2019 | Klein |
D871205 | December 31, 2019 | Farrell |
D873131 | January 21, 2020 | Watanabe |
D877613 | March 10, 2020 | McFaul |
10577165 | March 3, 2020 | Sadowski et al. |
D882415 | April 28, 2020 | Duarte de Castro |
D887283 | June 16, 2020 | Sennett |
D887700 | June 23, 2020 | Folger |
D892636 | August 11, 2020 | Troudt |
D898588 | October 13, 2020 | An |
D906102 | December 29, 2020 | Cook |
D909890 | February 9, 2021 | Bryzek |
D915904 | April 13, 2021 | Duarte de Castro |
D918710 | May 11, 2021 | Hampton |
D920573 | May 25, 2021 | Scudieri |
D934069 | October 26, 2021 | Cook |
D938831 | December 21, 2021 | Picken |
D939139 | December 21, 2021 | Waters |
11230419 | January 25, 2022 | Tilahun |
D945847 | March 15, 2022 | Chen |
D949018 | April 19, 2022 | Gysel |
D953886 | June 7, 2022 | Collier |
D957245 | July 12, 2022 | Müller |
D958645 | July 26, 2022 | Debnath |
D959052 | July 26, 2022 | Gerhards |
D961376 | August 23, 2022 | Cook |
20180085515 | March 29, 2018 | Mide et al. |
113226 | February 1992 | AU |
316236 | September 2007 | AU |
201713235 | June 2017 | AU |
2015001855 | December 2014 | CL |
2017001388 | January 2016 | CL |
2020001658 | June 2020 | CL |
2020001659 | June 2020 | CL |
2020001660 | June 2020 | CL |
2020001661 | June 2020 | CL |
09046884 | September 2009 | CO |
000243894-0001 | January 2005 | EM |
20200007409 | June 2020 | NC |
D139069 | February 2011 | TW |
D171654 | November 2015 | TW |
- Dispositivo de medicamento Spravato (Janssen Pharmaceutica NV) Jun. 3, 2019, https://www.scmp.com/news/world/united-states-canada/article/2188801/fda-approves-spravato-fast-acting-ketamine-nasal.
Type: Grant
Filed: Dec 18, 2019
Date of Patent: May 9, 2023
Assignee: Janssen Pharmaceutica NV (Beerse)
Inventors: Michael Cannamela (Atlantic Highlands, NJ), Emma Louise Hubert (San Jose, CA)
Primary Examiner: Rhea Shields
Application Number: 29/717,663